AGC Pharma News and Resources

AGC Pharma Chemicals and Ability Pharma have announced a strategic collaboration to develop ABTL0812, an active pharmaceutical ingredient (API) for treating pancreatic cancer. The collaboration will leverage AGC Pharma Chemicals’ extensive experience in process optimisation and scale-up to bring ABTL0812